- Home
- INKT vs PLCE Comparison
INKT vs PLCE Comparison
Compare INKT & PLCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INKT | PLCE |
|---|---|---|
| Founded | 2017 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.4M | 62.0M |
| IPO Year | 2021 | 1997 |
Fundamental Metrics
Financial Performance| Metric | INKT | PLCE |
|---|---|---|
| Price | $10.45 | $0.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $42.50 | N/A |
| AVG Volume (30 Days) | 14.3K | ★ 680.4K |
| Earning Date | 11-13-2026 | 12-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.48 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $44.74 | $4.75 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.48 | $0.36 |
| 52 Week High | $15.27 | $9.56 |
Technical Indicators
Market Signals| Indicator | INKT | PLCE |
|---|---|---|
| Relative Strength Index (RSI) | 45.59 | 10.34 |
| Support Level | $9.05 | N/A |
| Resistance Level | $12.27 | $2.88 |
| Average True Range (ATR) | 0.69 | 0.12 |
| MACD | 0.08 | -0.05 |
| Stochastic Oscillator | 51.74 | 7.33 |
Price Performance
Historical ComparisonAbout INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.
About PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.